IRIS
RAITERI, MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 29.683
Totale 29.683
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 29.683
Totale 29.683
Salva come PNG Salva come JPEG
Città #
Genova 23.544
Rapallo 2.799
Genoa 2.043
Vado Ligure 1.240
Bordighera 57
Totale 29.683
Salva come PNG Salva come JPEG
Nome #
Acute stress increases depolarization-evoked glutamate release and presynaptic SNARE complex accumulation in prefrontal/frontal cortex. The dampening action of antidepressants. 162
Activation of a glycine transporter on spinal cord neurons causes enhanced glutamate release in a mouse model of amyotrophic lateral sclerosis 157
CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex. 156
Activation of α6 GABAA receptors on depolarized cerebellar parallel fibers elicits glutamate release through anion channels 153
Subclassification of release-regulating a2-autoreceptors in human brain cortex. 145
Evidence for calcium-dependent vesicular transmitter release insensitive to tetanus toxin and botulinum toxin type F 144
A carrier for GABA uptake exists on noradrenaline nerve endings in selective rat brain areas but not on serotonin terminals 143
D-SERINE MODULATES THE NMDA RECEPTOR/NITRIC OXIDE/cGMP PATHWAY IN THE RAT CEREBELLUM DURING IN VIVO MICRODIALYSIS 143
Somatostatin-induced activation and up-regulation of N-methyl-D-aspartate receptor function: mediation through calmodulin-dependent protein kinase II, phospholipase C, protein kinase C, and tyrosine kinase in hippocampal noradrenergic nerve endings. 142
THe human immunodeficiency virus-1 envelope protein gp120 binds through its V3 sequence to the glycine site of N-methyl-D-aspartate receptors mediating noradrenaline release in the hippocampus 138
Heterologous carriers located on rat CNS nerve endings and their possible role in the modulation of transmitter release 138
Entrapping of impermeant probes of different size into nonpermeabilized synaptosomes as a method to study presynaptic mechanisms 137
INTRACEREBRAL ADMINISTRATION OF L-KYNURENINE DECREASES N-METHYL-D-ASPARTATE RECEPTOR-MEDIATED PRODUCTION OF cGMP IN THE CEREBELLUM AND HIPPOCAMPUS OF UNANAESTHETIZED RATS SUBJECTED TO TRANSCEREBRAL MICRODIALYSIS 136
Functional evidence for two native GABAA receptor subtypes in adult rat hippocampus and cerebellum. 135
Acetylcholine release from rat hippocampal slices is modulated by 5-hydroxytryptamine. 134
Release-regulating dopamine autoreceptors in human cerebral cortex. 134
Presynaptic receptors modulating transmitter release: physiological and pharmacological aspects 134
Alterations of glutamate release in the spinal cord of mice with experimental autoimmune encephalomyelitis 134
Release-regulating autoreceptors of the GABAB-type in human cerebral cortex 133
Age-related decrease of the NMDA receptor-mediated noradrenaline release in rat hippocampus and partial restoration by D-cycloserine 133
Glycine taken up through GLYT1 and GLYT2 heterotransporters into glutamatergic axon terminals of mouse spinal cord elicits release of glutamate by homotransporter reversal and through anion channels 131
Autoregulation of dopamine synthesis in striatal nerve endings 131
Cellular mechanisms of the acute increase of glutamate release induced by nerve growth factor in rat cerebral cortex. 131
Release-regulating GABAB autoreceptors in rat cerebral cortex slices 130
The activation of phosphatidylinositol turnover is not directly involved in the modulation of neurotransmitter release mediated by presynaptic muscarinic receptors 129
GABA induces norepinephrine exocytosis from hippocampal noradrenergic axon terminals by a dual mechanism involving different voltage-sensitive calcium channels 129
GM1 monosialoganglioside inner ester induces early recovery of striatal dopamine uptake in rats with unilateral nigrostriatal lesion 129
Activation of muscarinic receptors on striatal synaptosomes increases the release of endogenous dopamine 129
Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism 129
Cyclooxygenase-1 and -2 differently contribute to prostaglandin E2 synthesis and lipid peroxidation after in vivo activation of N-methyl-D-aspartate receptors in rat hippocampus. 129
N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus. 129
GABA terminal autoreceptors in the pars compacta and in the pars reticulata of the rat substantia nigra are GABAB 128
GABAB autoreceptors in rat cortex synaptosomes: response under different depolarizing and ionic conditions 128
Potentiation of NMDA receptor function through somatostatin release: a possible mechanism for the cognition-enhancing activity of GABAB receptor antagonists 128
Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus 128
A novel type of GABA receptor in rat spinal cord? 127
Functional expression of release-regulating glycine transporters GLYT1 on GABAergic neurons and GLYT2 on astrocytes in mouse spinal cord 126
Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release 126
The HIV-1 viral protein Tat modulates glutamate and GABA exocytosis from human and mouse neocortical nerve endings by acting at different binding sites. 125
Carrier-mediated and carrier-independent release of serotonin from isolated central nerve endings 125
5-hydroxytryptamine3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release 124
Noradrenaline inhibits central serotonin release through alpha2- adrenoceptors located on serotonergic nerve terminals 124
Calcium-dependent [3H]acetylcholine release and muscarinic autoreceptors in rat cortical synaptosomes during development 124
DESENSITIZATION OF AMPA RECEPTORS AND AMPA-NMDA RECEPTOR INTERACTION: AN IN VIVO CYCLIC GMP MICRODIALYSIS STUDY IN RAT CEREBELLUM 123
Serotonin-glutamate interactions in rat cerebellum: involvement of multiple 5-HT receptor subtypes 123
Co-Existence of GABA and Glu Transporters in the Central Nervous System 123
Evaluation of the mechanisms underlying the kainate-induced impairment of [3H]dopamine release in the rat striatum. 122
Presynaptic receptors as potential targets of psychotropic drugs 122
NK-3 receptor blockade prevents hyperalgesia and the associated spinal cord substance P release in monoarthritic rats 121
In vivo studies of glutamatergic receptors and NO pathways in brain 121
HIV-1 envelope protein gp120 potentiates NMDA-evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings 121
Chronic drug treatments induce changes in the sensitivity of presynaptic autoreceptors but not of presynaptic heteroreceptors 120
Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals in hippocampus 120
Ionic dysregulations typical of ischemia provoke release of glycine and GABA by multiple mechanisms 119
NK-3 receptors mediate enhancement of substance P release from capsaicin-sensitive spinal cord afferent terminals. 118
Excessive and precocious glutamate release in a mouse model of amyotrophic lateral sclerosis 118
Vasoactive intestinal polypeptide (VIP) potentiates the muscarinic stimulation of phosphoinositide turnover in rat cerebral cortex 118
(-)-Propranolol and (±)-cyanopindolol are mixed agonists-antagonists at serotonin autoreceptors in the hippocampus of the rat brain 118
Characterization of two central AMPA-preferring receptors having distinct location, function and pharmacology 118
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition 117
RANTES modulates the release of glutamate in human neocortex. 117
The HIV-1 coat protein gp120 and some of its fragments potently activate native cerebral NMDA receptors mediating neuropeptide release. 117
GM1 ganglioside treatment promotes recovery of electrically-stimulated 3H-dopamine release in striatal slices from rats lesioned with kainic acid 116
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids 116
GABA(B) presynaptic receptors modulate glycine exocytosis from mouse spinal cord and hippocampus glycinergic nerve endings 116
Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes 116
Role of external and internal calcium on heterocarrier-mediated transmitter release 116
Release of dopamine from human neocortex nerve terminals evoked by different stimuli involving extra- and intraterminal calcium 116
[3H]Pirenzepine binding in rat corpus striatum decreases after hemitransection of the nigro-striatal pathway 116
Nitric oxide-evoked glutamate release and cGMP production in cerebellar slices: Control by presynaptic 5-HT1D receptors 116
Glutamate release induced by activation of glycine and GABA transporters in spinal cord is enhanced in a mouse model of amyotrophic lateral sclerosis 116
Serotonin 5-HT1D and 5-HT1A receptors respectively mediate inhibition of glutamate release and inhibition of cyclic GMP production in rat cerebellum in vitro 115
Clonidine differentially modulates the release of endogenous GABA in various rat brain areas 115
Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120 115
Studies on a possible functional coupling between presynaptic acetylcholinesterase and high-affinity choline uptake in the rat brain 114
Dopamine release and dopaminergic inhibition of acetylcholine release in rat striatal slices after nigro-striatal hemitransection and parenteral ganglioside administration 114
Extracellular protons differentially potentiate the responses of native AMPA receptor subtypes regulating neurotransmitter release 114
Adaptation of presynaptic acetylcholine autoreceptors following long-term drug treatment 114
Serotonin receptors regulating transmitter release 114
Effects of some rigid analogues of imipramine and amitriptyline on the uptake of noradrenaline, serotonin and choline in rat brain synaptosomes 114
Somatostatin release from rat cerebral cortex synaptosomes 114
Cholinergic modulation of dopamine release in corpus striatum and substantia nigra of the rat 113
Selective block of rat and human neocortex GABA-B receptors regulating somatostatin release by a GABAB antagonist endowed with cognition enhancing activity 113
Release of endogenous glutamic and aspartic acids from cerebrocortex synaptosomes and its modulation through activation of a g-aminobutyric acidB (GABAB) receptor subtype. 112
Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors 112
Release-regulating presynaptic heterocarriers 112
Multiple mechanisms of transmitter release evoked by 'pathologically' elevated extracellular [K+]: involvement of transporter reversal and mitochondrial calcium 112
Presynaptic regulation of acetylcholine release in the CNS 112
ACTIVATION OF BRAIN NITRIC OXIDE SYNTHASE IN DEPOLARIZED HUMAN TEMPORAL CORTEX SLICES: DIFFERENTIAL ROLE OF VOLTAGE-SENSITIVE CALCIUM CHANNELS 111
Phaclofen antagonizes GABA at autoreceptors regulating release in rat cerebral cortex 111
Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in rat cerebellum: involvement of 5-hydroxytryptamine2C receptors. 111
Glycine release is regulated by metabotropic glutamate receptors sensitive to mGluR2/3 ligands and activated by N-acetylaspartylglutamate (NAAG) 111
Release of catecholamines, serotonin and acetylcholine from isolated brain tissue 110
In vivo effects of phosphodiesterase inhibition on basal cGMP levels in the pre-frontal cortex, hippocampus and cerebellum of freely moving rats. 110
IN VIVO MICRODIALYSIS STUDY OF A SPECIFIC INHIBITOR OF SOLUBLE GUANYLYL CYCLASE ON THE GLUTAMATE RECEPTOR/NITRIC OXIDE/CYCLIC GMP PATHWAY 110
GABA enhances acetylcholine release from hippocampal nerve endings through a mechanism blocked by a GABA uptake inhibitor 109
In vitro release of somatostatin from cerebral cortical slices: characterization of electrically evoked release 109
Sensitivity to selective adenosine A1 and A2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices 109
Functional damage of dopamine nerve terminals following intrastriatal kainic acid injection 109
Release-enhancing presynaptic muscarinic and nicotinic receptors coexist and interact on dopaminergic nerve endings of rat nucleus accumbens 109
Totale 12.338
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.724
article - articoli 70.272
book - libri 0
conference - conferenze 3.701
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 8.751
Totale 165.448
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.765 0 0 0 0 730 695 1.335 456 658 1.441 1.077 373
2020/20211.611 90 194 131 112 89 172 64 136 192 161 128 142
2021/20223.705 64 344 230 604 78 221 207 910 87 315 181 464
2022/20233.354 367 161 54 306 638 589 10 265 656 21 251 36
2023/20241.495 71 250 28 167 103 352 55 115 90 37 61 166
2024/20251.290 89 387 130 314 370 0 0 0 0 0 0 0
Totale 29.830